中文
Notice on Notification of Oversea Inspection Results of Rivastigmine Hydrogen Tartrate Capsules
Updated:2025-12-31

Sun Pharmaceutical Industries Ltd.:

Please note that on December 31, 2025, CFDI sent the Notification of Drug Remote Inspection Results of Rivastigmine Hydrogen Tartrate Capsules to the agency of the medicine in China.

If there are any questions, please do not hesitate to contact us as soon.

Contact: Lin maoquan

Tel.+86 10 68441672


Center for Food and Drug Inspection of NMPA
December 31, 2025